GO:0007292 female gamete generation: Oocyte Development Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0007292 female gamete generation describes the biological process that produces the specialised haploid egg cell (oocyte) through meiosis, which together with a male gamete participates in sexual reproduction.
• The process is a multi-stage programme that includes germ-cell specification, meiotic prophase, nuclear maturation, cytoplasmic maturation and the acquisition of oocyte competence.
• Meiotic divisions in the female germline are highly asymmetric, producing one large oocyte and small polar bodies, a feature that distinguishes female from male gamete generation.
• Epigenetic reprogramming, including H3K27me3 formation and its inheritance, is a hallmark of oocyte development and is controlled by counteracting histone-modifying activities.
• Prenatal androgen exposure can reprogram the female germline and transmit susceptibility to polycystic ovary syndrome across generations.
• Studying female gamete generation requires integrated models and methods, from Xenopus egg collection to CRISPR-based knockout, knock-in and overexpression cell models.
Description
Female gamete generation (GO:0007292) is the biological process by which a specialised haploid cell, the egg or oocyte, is produced through meiosis and becomes competent to participate in sexual reproduction alongside a male gamete. In biomedical research, this term is central to reproductive biology, developmental genetics and fertility medicine because defects in any stage of oocyte production can cause infertility, aneuploidy or transgenerational disease susceptibility. The process is not a single event but a coordinated programme that couples germ-cell specification, meiotic progression, cytoplasmic remodelling and epigenetic reprogramming. Understanding the molecular players that execute female gamete generation is therefore essential for interpreting reproductive phenotypes and for designing experiments that test causality. This article summarises the authoritative definition of GO:0007292, the stages and mechanisms that constitute it, the genes and regulatory layers involved, and the experimental and CRISPR-based methods used to study it.
female gamete generation At A Glance
| GO ID | GO:0007292 |
|---|---|
| GO term | female gamete generation |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Production of the haploid female gamete (oocyte/egg) through meiosis for sexual reproduction |
| Key cellular outcome | Formation of a mature oocyte competent for fertilisation |
| Associated processes | Meiosis, oocyte nuclear and cytoplasmic maturation, epigenetic reprogramming |
| Representative models | Mammalian oocytes, Xenopus laevis eggs, cultured germ cells |
| Disease relevance | Infertility, polycystic ovary syndrome, aneuploidy, transgenerational susceptibility |
What Is GO:0007292?
GO:0007292 female gamete generation is defined in the Gene Ontology as the generation of the female gamete, the specialised haploid cells produced by meiosis that, together with a male gamete, take part in sexual reproduction. In practical terms, it covers the developmental and cellular events that convert a diploid germ cell into a mature, fertilisable egg, including meiotic division, oocyte maturation and the acquisition of developmental competence.
Why Is female gamete generation Important in Cell Biology?
Female gamete generation is fundamental to sexual reproduction and to the transmission of genetic and epigenetic information across generations. Because the oocyte contributes not only the maternal genome but also the cytoplasm, organelles and epigenetic marks that guide early embryogenesis, defects in this process can cause infertility, miscarriage, chromosomal abnormalities and developmental disorders. Moreover, environmental or hormonal perturbations during oocyte development can have transgenerational consequences, as shown for prenatal androgen exposure and polycystic ovary syndrome susceptibility. Studying GO:0007292 therefore informs reproductive medicine, developmental biology and the growing field of epigenetic inheritance.
• Provides the maternal haploid genome required for sexual reproduction.
• Controls oocyte competence, a prerequisite for successful fertilisation and embryogenesis.
• Regulates meiotic chromosome segregation, whose failure causes aneuploidy.
• Establishes maternal epigenetic marks such as H3K27me3 that can be inherited.
• Is a target of endocrine disruption; prenatal androgen exposure alters the female germline.
• Underlies transgenerational susceptibility to polycystic ovary syndrome.
• Involves asymmetric meiotic divisions that are unique to the female germline.
• Requires coordination between nuclear maturation and cytoplasmic maturation.
• Is studied in model organisms such as Xenopus laevis for egg biochemistry and development.
• Offers targets for fertility preservation and reproductive toxicology research.
What Happens During female gamete generation?
Germ-cell specification and entry into meiosis
In simple terms: The process starts when germ cells are set aside and begin the special cell division that makes eggs.
Female gamete generation begins with the specification of germ cells and their entry into meiosis, the specialised reductive division that halves the chromosome number. In the female germline, meiosis initiates during fetal development and then arrests, setting the stage for later maturation. This early phase establishes the oocyte as a unique cell type that will eventually become a haploid egg capable of participating in sexual reproduction.
Meiotic divisions and asymmetry
In simple terms: The egg divides in a lopsided way so that one big cell keeps most of the resources.
Meiosis in the female germline is characterised by extreme asymmetry: each division produces a large oocyte and a small polar body, concentrating cytoplasmic and organellar resources in the future egg. This asymmetry is essential for oocyte competence and distinguishes female gamete generation from the more symmetric meiotic divisions of the male germline. Errors in meiotic chromosome segregation at this stage are a major source of aneuploidy in eggs.
Nuclear maturation
In simple terms: The nucleus of the egg gets ready by completing the meiotic divisions.
Nuclear maturation refers to the resumption and completion of meiosis, including germinal vesicle breakdown, chromosome condensation and progression to metaphase II. Oocyte competence develops through the synchronous coordination of nuclear maturation with cytoplasmic maturation, so that the oocyte is ready for fertilisation. This stage is a key checkpoint for developmental potential and is frequently assessed in reproductive research.
Cytoplasmic maturation and organelle remodelling
In simple terms: The body of the egg reorganises its contents so it can support an embryo.
Cytoplasmic maturation involves the redistribution and functional maturation of organelles, including mitochondria, endoplasmic reticulum and the centriolar machinery, which together support fertilisation and early embryogenesis. The centriole and centrosome components are particularly important because they influence the inheritance of the centrosome and the first embryonic divisions. Synchrony between nuclear and cytoplasmic maturation is required for full oocyte competence.
Epigenetic reprogramming and maternal marks
In simple terms: The egg writes chemical marks on its DNA packaging that can be passed to the next generation.
During oocyte development, the maternal epigenome is extensively reprogrammed, including the formation and inheritance of repressive histone marks such as H3K27me3. The counteraction between H2AK119ub1 and MLL2 underlies heritable H3K27me3 formation in oocytes, linking chromatin regulation to the maternal epigenetic legacy. These marks can influence gene expression after fertilisation and contribute to transgenerational effects.
Fertilisation competence and gamete choice
In simple terms: The finished egg is ready to be fertilised and can influence which sperm succeeds.
The endpoint of female gamete generation is a mature oocyte competent for fertilisation. Maternal control of gamete choice during fertilisation indicates that the egg is not a passive partner but can influence the outcome of sperm-egg interaction. This final stage integrates the nuclear, cytoplasmic and epigenetic maturation events that define a functional female gamete.
Key Genes Involved in GO:0007292 female gamete generation
The following genes and proteins represent major functional categories within female gamete generation, from meiotic control to epigenetic reprogramming and fertilisation competence.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MLL2 (KMT2D) | Histone methyltransferase involved in H3K27me3 formation in oocytes | Epigenetic inheritance studies in oocytes |
| H2AK119ub1 pathway components | Counteract MLL2 to regulate heritable H3K27me3 | Chromatin reprogramming in female gametes |
| Centriolar proteins (e.g. PLK4, SAS-6) | Centriole duplication and centrosome inheritance | Fertilisation and early embryonic division |
| Meiotic recombination machinery (e.g. SPO11, DMC1) | Initiate and execute meiotic recombination | Aneuploidy and infertility research |
| Spindle assembly checkpoint components | Monitor chromosome segregation during meiosis | Meiotic error and aneuploidy studies |
| Maturation promoting factor components (CDK1, cyclin B) | Drive meiotic resumption and nuclear maturation | Oocyte maturation assays |
| Cytoplasmic maturation regulators | Coordinate organelle remodelling with nuclear maturation | Oocyte competence research |
| Androgen receptor signalling components | Mediate androgen effects on the female germline | PCOS and transgenerational susceptibility |
| Maternal effect genes | Provide transcripts and proteins for early development | Fertilisation and embryo studies |
| Xenopus egg extract proteins | Support biochemical studies of egg cytoplasm | Egg collection and developmental biochemistry |
| Methylxanthine targets (e.g. phosphodiesterases) | Modulate reproductive processes | Reproductive pharmacology |
| Centrosome inheritance factors | Regulate centriole inheritance at fertilisation | Centriole biology in reproduction |
| Epigenetic erasers and writers | Establish and remove maternal histone marks | Transgenerational epigenetics |
| Fertilisation membrane proteins | Mediate sperm-egg interaction | Gamete choice and fertilisation |
| Meiotic cohesin complex | Hold sister chromatids during meiosis | Chromosome segregation fidelity |
| Oocyte-specific transcription factors | Drive oocyte gene expression programmes | Oocyte development studies |
| Polar body formation regulators | Control asymmetric division | Female meiosis asymmetry |
How Is female gamete generation Regulated?
Female gamete generation is regulated at multiple levels. Hormonal signals, including androgens, can reprogram the female germline during development and alter susceptibility to polycystic ovary syndrome in subsequent generations. Epigenetic regulation is central: the balance between H2AK119ub1 and MLL2 activity controls heritable H3K27me3 formation in oocytes, providing a mechanism for transmitting chromatin states through the female germline. Meiotic progression is regulated by cell-cycle machinery that coordinates nuclear maturation with cytoplasmic maturation, ensuring that oocyte competence develops synchronously. In addition, pharmacological agents such as methylxanthines can modulate reproductive processes, indicating that signalling pathways involving phosphodiesterases and cyclic nucleotides influence gamete generation. Maternal control of gamete choice during fertilisation further shows that the oocyte actively regulates post-fertilisation events.
female gamete generation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Androgen receptor pathway | Polycystic ovary syndrome susceptibility | Knockout or point-mutation cell models of androgen signalling |
| MLL2 (KMT2D) | Epigenetic inheritance defects | Knockout and knock-in oocyte-like cell models |
| Meiotic recombination genes | Aneuploidy and infertility | Knockout models with meiotic segregation assays |
| Centriolar proteins | Fertilisation and centrosome inheritance defects | Tagged knock-in for centriole imaging |
| Maternal effect genes | Early developmental failure | Overexpression and knockout in gamete models |
Polycystic ovary syndrome and transgenerational susceptibility
Prenatal androgen exposure can reprogram the female germline and transmit susceptibility to polycystic ovary syndrome across generations, linking female gamete generation to a common endocrine disorder. This highlights how perturbations during oocyte development can have lasting reproductive and metabolic consequences.
Aneuploidy and meiotic errors
Errors in the asymmetric meiotic divisions of the female germline are a major cause of aneuploidy in eggs, which is associated with miscarriage and chromosomal disorders. Understanding the mechanisms that ensure accurate chromosome segregation during female gamete generation is therefore clinically important.
Infertility and oocyte competence
Oocyte competence depends on the synchronous development of nuclear and cytoplasmic maturation; when this coordination fails, fertilisation and embryo development can be compromised. Research into female gamete generation directly informs the diagnosis and management of infertility.
Epigenetic inheritance and developmental disorders
Heritable H3K27me3 formation in oocytes, controlled by H2AK119ub1-MLL2 counteraction, provides a mechanism by which epigenetic states are transmitted to the next generation. Disruption of these processes may contribute to developmental disorders and transgenerational phenotypes.
From female gamete generation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for meiotic progression? | CRISPR knockout in germ-cell-like or oocyte models |
| Does a specific variant alter oocyte maturation? | Point-mutation knock-in cell model |
| How does a maternal epigenetic mark behave? | Tagged knock-in of histone modifiers |
| Does overexpression of a maternal factor enhance competence? | Overexpression cell model |
| Which genes mediate androgen effects on the germline? | Knockout and overexpression models of androgen signalling |
| How do centriolar proteins behave during fertilisation? | Tagged knock-in and imaging models |
How to Study the female gamete generation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Oocyte maturation assay | Germinal vesicle breakdown and polar body extrusion | Assessing nuclear maturation |
| Organelle imaging | Distribution of mitochondria and ER | Cytoplasmic maturation studies |
| Xenopus egg collection | Yield and quality of eggs | Biochemical and developmental experiments |
| ChIP for histone marks | H3K27me3 and H2AK119ub1 levels | Epigenetic reprogramming in oocytes |
| Meiotic chromosome spreads | Recombination and segregation | Aneuploidy research |
| Fertilisation assays | Sperm-egg interaction and gamete choice | Maternal control of fertilisation |
| Reproductive pharmacology assays | Effects of methylxanthines on gametes | Reproductive toxicology |
| Transgenerational phenotyping | Offspring susceptibility to disease | PCOS model studies |
Oocyte maturation assays
Nuclear and cytoplasmic maturation can be assessed by tracking germinal vesicle breakdown, polar body extrusion and organelle distribution, providing a functional readout of oocyte competence. These assays are used to determine whether a gene perturbation affects the timing or success of maturation.
Egg collection and biochemical analysis
Model organisms such as Xenopus laevis allow large-scale egg collection for biochemical and developmental studies, enabling analysis of cytoplasmic components that support female gamete generation. Such preparations are valuable for testing the function of maternal factors.
Epigenetic profiling
Chromatin immunoprecipitation and related approaches can measure histone marks such as H3K27me3 and H2AK119ub1 in oocytes, revealing how epigenetic reprogramming contributes to female gamete generation. These methods are essential for studying transgenerational inheritance.
Meiotic chromosome analysis
Cytogenetic and imaging methods can evaluate chromosome segregation, recombination and spindle integrity during female meiosis, identifying sources of aneuploidy. Combining these with genetic perturbation helps establish causal roles for specific genes.
How CRISPR Can Be Used to Study GO:0007292 female gamete generation
Knockout
CRISPR knockout can be used to remove candidate genes and test whether they are required for female gamete generation, for example by assessing meiotic progression or oocyte maturation. Knockout models help distinguish essential from redundant factors in the process.
Point Mutation
Point-mutation knock-in allows researchers to model specific variants in genes involved in female gamete generation, such as those affecting meiotic recombination or maturation, and to test their functional consequences. This approach is valuable for linking genotype to reproductive phenotype.
Knock-in
Tagged knock-in of genes encoding histone modifiers or centriolar proteins enables live imaging and biochemical tracking of their products during oocyte development and fertilisation. Such models are useful for studying epigenetic marks and organelle inheritance.
Overexpression
Overexpression models can test whether increased levels of maternal factors enhance or disrupt oocyte competence and fertilisation, providing gain-of-function evidence for gene function in female gamete generation. They complement loss-of-function approaches.
How EDITGENE Supports female gamete generation Research
Researchers studying female gamete generation-related genes often need to determine whether a candidate gene is causally involved in oocyte development, meiotic progression or fertilisation competence. Establishing causality requires precise genetic models that can remove, modify, tag or overexpress the gene of interest in relevant cell systems. EDITGENE provides a suite of CRISPR-based services designed to support such studies, from single-gene knockout to library screening and bioinformatics analysis.
Contact EDITGENE today to design your custom CRISPR model for female gamete generation research.
Frequently Asked Questions About female gamete generation
What is GO:0007292 female gamete generation?
GO:0007292 is the Gene Ontology biological process describing the generation of the female gamete, the specialised haploid cell produced by meiosis that participates in sexual reproduction together with a male gamete.
What happens during female gamete generation?
The process includes germ-cell specification, meiotic divisions, nuclear and cytoplasmic maturation, epigenetic reprogramming and the acquisition of fertilisation competence.
What genes are involved in female gamete generation?
Genes involved include histone modifiers such as MLL2, meiotic recombination machinery, centriolar proteins, maturation regulators and maternal effect genes.
Why is female gamete generation important for fertility?
Oocyte competence depends on the coordinated nuclear and cytoplasmic maturation that occurs during female gamete generation, so defects can cause infertility.
How is female gamete generation linked to polycystic ovary syndrome?
Prenatal androgen exposure can reprogram the female germline and transmit susceptibility to polycystic ovary syndrome across generations.
What is the role of epigenetics in female gamete generation?
Epigenetic reprogramming, including H3K27me3 formation controlled by H2AK119ub1-MLL2 counteraction, is a hallmark of oocyte development and can be inherited.
How do researchers study female gamete generation?
Researchers use oocyte maturation assays, egg collection from model organisms, epigenetic profiling and meiotic chromosome analysis.
Can CRISPR be used to study female gamete generation?
Yes, CRISPR knockout, point-mutation knock-in, tagged knock-in and overexpression models can test the function of candidate genes in this process.
What model organisms are used for female gamete generation research?
Mammalian oocytes and Xenopus laevis eggs are widely used, with Xenopus allowing large-scale egg collection for biochemical studies.
What diseases are associated with defects in female gamete generation?
Defects are associated with infertility, aneuploidy, polycystic ovary syndrome and transgenerational susceptibility to disease.
Conclusion
GO:0007292 female gamete generation defines the essential biological process that produces the haploid egg through meiosis, nuclear and cytoplasmic maturation, and epigenetic reprogramming. Its correct execution is required for fertility and for the transmission of genetic and epigenetic information to the next generation. Perturbations in this process are linked to polycystic ovary syndrome, aneuploidy and infertility, making it a key area of reproductive and developmental research. CRISPR-based models, including knockout, point-mutation knock-in, tagged knock-in and overexpression, provide powerful tools to dissect the causal roles of genes in female gamete generation and to translate findings into clinical insight.
References
- 1. Risal S et al.. 2019. Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome.. Nat Med 25(12):1894-1904 PMID: 31792459
- 2. Avidor-Reiss T et al.. 2019. It takes two (centrioles) to tango.. Reproduction 157(2):R33-R51 PMID: 30496124
- 3. Minelli A et al.. 2011. Methylxanthines and reproduction.. Handb Exp Pharmacol PMID: 20859803
- 4. Torkashvand H et al.. 2024. Oocyte competence develops: nuclear maturation synchronously with cytoplasm maturation.. Zygote 32(6):421-428 PMID: 39552507
- 5. Shaidani NI et al.. 2021. Obtaining Xenopus laevis Eggs.. Cold Spring Harb Protoc 2021(3):pdb.prot106203 PMID: 33272976
- 6. Mei H et al.. 2026. H2AK119ub1-MLL2 counteraction underlies heritable H3K27me3 formation in oocytes.. Mol Cell 86(9):1691-1707.e7 PMID: 41980776
- 7. El Yakoubi W et al.. 2017. Meiotic Divisions: No Place for Gender Equality.. Adv Exp Med Biol 1002:1-17 PMID: 28600780
- 8. Nair S. 2020. Maternal control of gamete choice during fertilization.. Int J Dev Biol 64(1-2-3):175-180 PMID: 32659006
